萆菟汤治疗慢性非细菌性前列腺炎110例  

Clinical Efficacy of Bitu Decoction in Treatment of Chronic Abacterial Prostatitis:A Report of 110 Cases

作　　者：张凯[1] 时荣同 马楠[1] 孔德志[1] 

机构地区：[1]皖北煤电集团总医院泌尿外科,安徽宿州234000

出　　处：《安徽中医药大学学报》2015年第4期28-31,共4页Journal of Anhui University of Chinese Medicine

摘　　要：目的观察萆菟汤治疗慢性非细菌性前列腺炎(chronic abacterial prostatitis,CAP)的临床疗效。方法将176例CAP患者随机分为治疗组110例和对照组66例,分别采用萆菟汤和前列康片治疗,疗程均为8周。观察并比较两组临床疗效,治疗前后分别观察两组NIH-CPSI评分,并进行挤压前列腺分泌液(expressed prostatic secretion,EPS)常规检查。结果治疗组临床疗效明显优于对照组(P<0.05)。与治疗前比较,两组治疗后NIH-CPSI的疼痛症状、排尿症状、生活质量评分和总分均显著降低(P<0.05),治疗组上述评分降低值显著大于对照组(P<0.05)。与治疗前比较,两组治疗后EPS中白细胞计数及pH值均显著降低(P<0.05),卵磷脂小体计数均显著升高(P<0.05);治疗组治疗后白细胞计数降低值小于对照组(P<0.05),卵磷脂小体升高值和pH值降低值大于对照组(P<0.05)。结论萆菟汤对CAP具有显著的临床疗效。Objective To observe the clinical efficacy of Bitu Decoction in the treatment of chronic abacteri- al prostatitis （CAP）. Methods A total of 176 CAP patients were randomly divided into control group （n=66） and treatment group （n=110）. The treatment group received Bitu Decoction, while the control group received Qianliekang Tablet. The course of treatment was 8 weeks for both groups. The treatment outcome was compared between the two groups; before and after treatment, the National Institutes of Health Chronic Prostatitis Symptom Index （NIH-CPSI） scores of the two groups were determined, and expressed prostatic secretion （EPS） examination was performed. Results The treatment group had a sig- nificantly better treatment outcome than the control group （P〈0. 05）. After treatment, both groups showed significant decreases in the pain, urinary, and quality of life scores and total score of NIH-CPSI （P^0.05）, and the treatment group had significantly higher decreases in the above scores than the control group （P〈0.05）. In addition, the two groups had significantly reduced white blood cell （WBC） count and pH value （P〈0.05） but significantly increased small particles of lecithin （SPL） （P〈0.05） in EPS exami- nation; compared with the control group, the treatment group had a significantly lower decrease in WBC count （P〈0.05）, a significantly higher increase in SPL （P〈0.05）, and a significantly higher decrease in pH value （P〈0.05）. Conclusion Bitu Decoction has significant clinical efficacy in the treatment of CAP.

关 键 词：慢性非细菌性前列腺炎 萆菟汤 前列康 NIH-CPSI 

分 类 号：R697.3[医药卫生—泌尿科学]